| Open Document File Size: 67,79 KBShare Result on Facebook
City Philadelphia / / Company ARIAD Pharmaceuticals / / Event FDA Phase / Man-Made Disaster / / IndustryTerm multi-site / healthcare professionals / treatment of patients with chronic myeloid leukemia / investigational new drug applications / food / / MedicalCondition T315I-positive chronic myeloid leukemia / positive acute lymphoblastic leukemia / leukemia / chest pain / disease / severe peripheral vascular disease / blast phase / shortness of breath / venous thrombosis / stroke / thromboembolism / observed arterial and venous thrombosis / blood clots / numbness / fatal myocardial infarction / pain in their arms / heart attack / Arterial and venous thrombosis / severe headache / chronic phase / pulmonary embolism / extremity necrosis / chronic myeloid leukemia / dizziness / / Organization U.S. Food and Drug Administration / FDA / / Product The patient Medication / Iclusig / FDA Drug / / ProvinceOrState Indiana / / URL http /
SocialTag |
FDA Drug Safety Communication: FDA requires multiple new safety measures for leukemia drug Iclusig; company expected to resume marketing This information is in follow-up to the FDA Drug Safety Communication: FDA asks man